Weekly signal · MKSI · Technology

MKS Instruments Inc (MKSI) adds 17.9% as weekly setup strengthens

The roughly $22 billion Technology name is showing confirmation beyond price, though volume signals are not fully aligned.

MKS Instruments Inc
Latest355.69 USD
1W move17.9%
Volume1.0x
TrendActive
Weekly market chart context for MKS Instruments stock alongside scientific process-control equipment.

Market update

What happened

MKS Instruments Inc (MKSI) closed the week ended June 12 at 355.69 USD, with the stock up 17.9% over one week and 17.4% over four weeks.

The chart is a weekly price path over 52 weeks, so this is weekly context rather than live intraday action. The trend signal is active, with momentum confirmation offset by mixed volume evidence.

Continue your research

Explore MKSI across Sharemaestro

These links are shown because current Sharemaestro data is available for this company.

Interactive chartReview weekly price, Trend Line, Fair Value, volume and Relative Strength.Full weekly reportOpen the full company report, financial profile and peer comparison.Technical analysisExamine support, resistance, momentum and the current trend readings.Stage analysisSee whether the stock is basing, advancing, distributing or declining.Trend historyReview how long the current trend has persisted and where it has changed.Sector comparisonCompare sector returns, breadth, leaders and weaker areas.Industry comparisonSee how this company’s industry is performing across its members.Company factorsCompare value, quality, growth, momentum and financial strength.News sentimentSee the balance, quality and freshness of recent company coverage.Buying and selling pressureReview longer-term accumulation, distribution and reversal readings.EarningsReview report dates, estimates, past results and earnings surprises.Options activitySee options positioning, expected move and unusual trading activity.Short interestReview short positioning, crowding and possible squeeze risk.Insider transactionsSee reported purchases and sales by company directors and executives.

MKSI coverage

Evidence context